articleThe Lancet OncologyDec 15, 2014Closed access

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

University of Würzburg · Universitäts-Kinderklinik Würzburg · +21 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,252
total citations
FWCI
130.23
Percentile
100%
References
29
Citations per year

Authors

25

Topics & keywords

Keywords
  • Blinatumomab
  • Medicine
  • Neutropenia
  • Internal medicine
  • Refractory (planetary science)
  • Clinical endpoint
  • Febrile neutropenia
  • Adverse effect
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding